Mannkind (MNKD) Change in Acquisitions & Divestments (2011 - 2026)
Mannkind's (MNKD) quarterly Change in Acquisitions & Divestments came in at $30.9 million in Q1 2026, down 38.67% year-on-year from $50.4 million in Q1 2025, and down 56.77% on a QoQ basis from $71.5 million in Q4 2025.
Mannkind (MNKD) Change in Acquisitions & Divestments (2011 - 2026) Analysis & Trends
Mannkind (MNKD) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $30.9 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 38.67% year-over-year to $30.9 million in Q1 2026; TTM through Mar 2026 was $195.8 million, a 19.59% increase from a year earlier, with the FY2025 full-year figure at $215.3 million, up 59.11% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $30.9 million, down from $71.5 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for MNKD reached as high as $71.5 million in Q4 2025 and fell as low as $22.0 million in Q1 2024.
- Historically, Change in Acquisitions & Divestments has averaged $38.0 million across 5 years, with a median of $30.1 million in 2022.
- Across the five-year window, Change in Acquisitions & Divestments jumped 892200.0% in 2022 and tumbled 38.67% in 2026, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $24.8 million in 2022, then rose by 7.28% to $26.6 million in 2023, then soared by 75.1% to $46.5 million in 2024, then soared by 53.74% to $71.5 million in 2025, then tumbled by 56.77% to $30.9 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $30.9 million in Q1 2026, $71.5 million in Q4 2025, and $42.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Mannkind | 1.23 Bn | 1.10 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.91 Mn |
| Mar 31, 2026 | 30.91 Mn |
| Dec 31, 2025 | 71.50 Mn |
| Dec 31, 2025 | 71.50 Mn |
| Sep 30, 2025 | 42.02 Mn |
| Sep 30, 2025 | 42.02 Mn |
| Jun 30, 2025 | 51.40 Mn |
| Jun 30, 2025 | 51.40 Mn |
| Mar 31, 2025 | 50.40 Mn |
| Mar 31, 2025 | 50.40 Mn |
| Sep 30, 2024 | 46.50 Mn |
| Sep 30, 2024 | 46.50 Mn |
| Jun 30, 2024 | 66.84 Mn |
| Jun 30, 2024 | 66.84 Mn |
| Mar 31, 2024 | 21.97 Mn |
| Mar 31, 2024 | 21.97 Mn |
| Dec 31, 2023 | 26.56 Mn |
| Dec 31, 2023 | 26.56 Mn |
| Sep 30, 2023 | 23.53 Mn |
| Sep 30, 2023 | 23.53 Mn |